Performance of the Endurant stent graft in patients with abdominal aortic aneurysms independent of their morphologic suitability for endovascular aneurysm repair based on instructions for use

Donas, Konstantinos P.; Torsello, Giovanni; Weiss, Kristin; Bisdas, Theodosios; Eisenack, Markus; Austermann, Martin

doi:10.1016/j.jvs.2015.04.434

Cited by 20 publications

(15 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous studies have since shown excellent midterm outcomes and rates of technical success with the device. 2,3,13,14 The data presented in this article confirm the long-term safety and durability of the Endurant system out to 5 years. The observation of only a single rupture at 4 years (day 1212), freedom from open surgical conversion, and freedom from aneurysm-related death (99.2%) supports the excellent long-term durability of the Endurant stent graft.…”

Section: Discussionsupporting

confidence: 74%

“…Treating patients with adverse proximal aortic necks (<10 mm) has been reported with acceptable short-term results. 13,14 However, an increased rate of type I endoleaks and mid-to late-term endograft migration is expected. The mean neck length treated in the study was 26.5 6 12.1 mm and 15 patients (10%) had neck lengths of 10 to 14.9 mm.…”

Section: Discussionmentioning

confidence: 99%

“…These characteristics appear to improve sealing in short or angulated necks and may improve device flexibility. 2,13,14 Conflicting evidence exists regarding deterioration of renal function following EVAR with suprarenal fixation. Patients with baseline creatinine >2.00 mg/dL and those on dialysis were excluded from study enrollment.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Final results of the Endurant Stent Graft System in the United States regulatory trial

Singh

Fairman

Anain³

et al. 2016

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 74%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Final results of the Endurant Stent Graft System in the United States regulatory trial

Singh

Fairman

Anain³

et al. 2016

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Recent studies focused on the feasibility and the outcomes of Endurant II (Medtronic) used off-label. These studies also reported a higher incidence of type Ia endoleak and iliac limb occlusion for off-label stent use compared with patients treated under IFU (13)(14)(15).…”

Section: • September-october 2016 • Diagnostic and Interventional Radmentioning

confidence: 86%

Clinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use

Pecoraro

Corte²,

Dinoto³

et al. 2016

Diagn Interv Radiol

View full text Add to dashboard Cite

C omputed tomography (CT) colonography is a noninvasive method for colorectal carcinoma screening and was shown to be highly sensitive for colorectal cancer and polyp detection in previous studies (1-4). The major problem for diagnostic and screening CT colonography is differentiation of tumor and polyps from stool. Therefore, several methods are used for this purpose such as prone and supine imaging (looking for movement of stool), use of laxatives (to clear stool from colon), barium tagging (to mark stools with barium) and density measurements (5). However, some patients can refuse or cannot tolerate bowel preparation leading to cancellation of CT colonography examinations. For patients who do not tolerate bowel preparation, laxative-free or reduced preparation protocols have been developed. Dual-energy computed tomography (DECT) is becoming increasingly used for body computed tomography (CT) applications (6-8). The major advantage of DECT is its ability to obtain iodine map and virtual noncontrast (VNC) images in a single CT study by acquiring two datasets with different kilovolts. On contrast-enhanced single-energy CT images, the density of a measured area is equal to basal density of the area plus the density increment due to iodine uptake. DECT allows measurement of basal density and the degree of iodine uptake on VNC and iodine map images, respectively, without acquiring unenhanced CT images (9). Pilot studies reported utility of DECT principle for diagnostic CT colonography and electronic cleansing after barium tagging for CT colonography (5, 10, 11). Recent studies showed that colorectal cancer can be detected without bowel preparation by DECT (12) A B D O M I N A L I MAG I N G O R I G I N A L A R T I C L E PURPOSEWe aimed to determine dual-energy computed tomography (DECT) characteristics of colorectal cancer and investigate effectiveness of DECT method in differentiating tumor from stool in patients with colorectal cancer. METHODSFifty consecutive patients with colorectal tumors were enrolled. Staging was performed by DECT (80-140 kV) using dual-source CT after rectal air insufflation and without bowel preparation. Both visual and quantitative analyses were performed at 80 kV and 140 kV, on iodine map and virtual noncontrast (VNC) images. RESULTSAll colorectal tumors had homogeneous pattern on iodine map. Stools demonstrated heterogeneous pattern in 86% (43/50) and homogeneous pattern in 14% (7/50) on iodine maps and were less visible on VNC images. Median density of tumors was 54 HU (18-100 HU) on iodine map and 28 HU (11-56 HU) on VNC images. Median density of stool was 36.5 HU (8-165 HU) on iodine map and -135.5 HU (-438 HU to -13 HU) on VNC images. The density of stools was significantly lower than tumors on both iodine map and VNC images (P < 0.001). The cutoff point of density measurement on VNC images was -1 HU with area under the curve of 1 and a sensitivity and specificity of 100%. CONCLUSIONDensity or visual analysis of iodine map and VNC DECT images allow accurate differentiation of tumor ...

show abstract

“…3,4,8 Other papers that studied both stent grafts showed similar freedom from secondary intervention rates. [9][10][11] On the other hand, comparisons of the Talent and Endurant showed that the performance of the latter appears to be better. 7,12 The results of the U.S. regulatory pivotal trials of the Endurant and Talent were compared, showing favorable outcomes for the Endurant.…”

Section: Discussionmentioning

confidence: 99%

Comparison of midterm results for the Talent and Endurant stent graft

Mannetje

Cuypers

Saleem

et al. 2017

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Performance of the Endurant stent graft in patients with abdominal aortic aneurysms independent of their morphologic suitability for endovascular aneurysm repair based on instructions for use

Abstract: The performance of the Endurant stent graft during a period of 7 years under real-life conditions was good, with low incidence of reinterventions and endoleaks.

Cited by 20 publications

References 12 publications

Final results of the Endurant Stent Graft System in the United States regulatory trial

Final results of the Endurant Stent Graft System in the United States regulatory trial

Clinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use

Comparison of midterm results for the Talent and Endurant stent graft

Contact Info

Product

Resources

About